News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 750 results

Merck & Co in $2.7bn cancer research acquisition

12-12-2019Rory O'Neill

Merck & Co has announced its acquisition of cancer research biotech ArQule in a $2.7 billion deal.

Sanofi buys Synthorx for $2.5 billion

US10-12-2019Saman Javed

Sanofi is to acquire Synthorx, a biotechnology company focused on improving the lives of people suffering from cancer and autoimmune diseases, for $2.5 billion.

Munich court rules for Bio-Rad in 10x Genomics dispute

Germany03-12-2019Rory O'Neill

California-based Bio-Rad Laboratories has obtained an injunction from a German court in its long-running dispute with US biotechnology company 10x Genomics.

DLA Piper hires Arnold & Porter counsel

US27-11-2019Sarah Morgan

DLA Piper has strengthened its San Francisco office with the addition of a former Arnold & Porter Kaye Scholer counsel.

LSPN Europe: understand our business models, say in-house lawyers

26-11-2019Tom Phillips

The best lawyers acting for life sciences companies make sure they fully understand their clients’ business models, said in-house counsel at Life Sciences Patent Network 2019.

US charges ex-Monsanto employee with stealing trade secrets for China

China, US22-11-2019Saman Javed

The US Department of Justice has charged a former Monsanto employee with committing economic espionage and trade secrets theft.

LSPN Europe: AIs should be named inventors, argues Dabus professor

EU, UK, US21-11-2019Tom Phillips

The team leader behind the world’s first artificial intelligence-generated patent application has said AI inventors will force major changes to the patent system.

Roche buys fibrotic diseases biotech in $1.4bn deal

Switzerland, US19-11-2019

Switzerland-based Roche has agreed to acquire Promedior and its portfolio of molecules for serious fibrotic diseases. 

Regents of the University of Michigan file patent suit against microscope maker

US18-11-2019Saman Javed

The Regents of the University of Michigan have sued an optical microscope manufacturer for allegedly infringed one of its patents.

Seattle Genetics requests arbitration to resolve Daiichi Sankyo dispute

Japan14-11-2019Saman Javed

Seattle Genetics has asked the American Arbitration Association to help resolve a dispute with Daiichi Sankyo, alleging that the Japanese pharma company used its technology to create a number of drugs.

Showing 1 to 10 of 750 results

LSIPR